Riboflavin/UV-A corneal phototherapy as stand-alone management of ulcerative keratitis in dogs
Status PubMed-not-MEDLINE Language English Country Czech Republic Media electronic-ecollection
Document type Journal Article
PubMed
39170804
PubMed Central
PMC11334441
DOI
10.17221/46/2021-vetmed
PII: 121046
Knihovny.cz E-resources
- Keywords
- corneal melting, corneal ulcer, cross-linking, keratitis, riboflavin; UV-A,
- Publication type
- Journal Article MeSH
Corneal ulcers are one of the most common ocular disorders in veterinary ophthalmology and several factors can negatively influence the efficacy of the currently available therapeutic options, leading to a loss of corneal transparency and, thus, vision. Twenty-five dogs with clinical signs of corneal ulcers were randomised to receive either corneal phototherapy (16 dogs; study group) or topical standard medical therapy (9 dogs; control group). The riboflavin/UV-A corneal phototherapy (PACK-CXL) consisted in the application of a riboflavin ophthalmic solution (Visioflavin®; Vision Engineering Italy srl, Rome, Italy) onto the cornea for 20 min followed by 30 mW/cm2 UV-A irradiance for 3 min using a point-of-care UV-A device (Vetuvir®; Vision Engineering Italy srl, Rome, Italy). The complete healing of the ulcerative lesion was defined as the complete restoration of the corneal epithelial integrity with negative fluorescein staining. The corneal phototherapy achieved complete corneal healing in all the dogs by 20.5 ± 7.8 days. In the control group, only two dogs achieved complete healing by 21.5 ± 15.6 days. This intervention may represent a valid option to hasten corneal wound healing and a clinical resolution of ulcerative keratitis in dogs.
CNR IPCF Istituto per i Processi Chimico Fisici Messina Italy
Department of Veterinary Medicine University of Perugia Perugia Italy
School of Biosciences and Veterinary Medicine University of Camerino Matelica Italy
See more in PubMed
Brejchova K, Liskova P, Cejkova J, Jirsova K. Role of matrix metalloproteinases in recurrent corneal melting. Exp Eye Res. 2010 May;90(5):583-90. PubMed
De Briyne N, Atkinson J, Pokludova L, Borriello SP. Antibiotics used most commonly to treat animals in Europe. Vet Rec. 2014 Oct 4;175(13):325. PubMed PMC
Brooks DE, Ollivier FJ. Matrix metalloproteinase inhibition in corneal ulceration. Vet Clin North Am Small Anim Pract. 2004 May;34(3):611-22. PubMed
Cain CL. Antimicrobial resistance in staphylococci in small animals. Vet Clin North Am Small Anim Pract. 2013 Jan;43(1):19-40. PubMed
Famose F. Assessment of the use of spectral domain optical coherence tomography (SD-OCT) for evaluation of the healthy and pathological cornea in dogs and cats. Vet Ophthalmol. 2014a Jan;17(1):12-22. PubMed
Famose F. Evaluation of accelerated collagen cross-linking for the treatment of melting keratitis in eight dogs. Vet Ophthalmol. 2014b Sep;17(5):358-67. PubMed
Famose F. Evaluation of accelerated collagen cross-linking for the treatment of melting keratitis in ten cats. Vet Ophthalmol. 2015 Mar;18(2):95-104. PubMed
Famose F. Evaluation of accelerated corneal collagen cross-linking for the treatment of bullous keratopathy in eight dogs (10 eyes). Vet Ophthalmol. 2016 May;19(3):250-5. PubMed
Fini ME, Cook JR, Mohan R. Proteolytic mechanisms in corneal ulceration and repair. Arch Dermatol Res. 1998 Jul;290(Suppl):S12-23. PubMed
Gallhoefer NS, Spiess BM, Guscetti F, Hilbe M, Hartnack S, Hafezi F, Pot SA. Penetration depth of corneal cross-linking with riboflavin and UV-A (CXL) in horses and rabbits. Vet Ophthalmol. 2016 Jul;19(4):275-84. PubMed
Goulle F. Use of porcine small intestinal submucosa for corneal reconstruction in dogs and cats: 106 cases. J Small Anim Pract. 2012 Jan;53(1):34-43. PubMed
Hayes S, Kamma-Lorger CS, Boote C, Young RD, Quantock AJ, Rost A, Khatib Y, Harris J, Yagi N, Terrill N, Meek KM. The effect of riboflavin/UVA collagen cross-linking therapy on the structure and hydrodynamic behaviour of the ungulate and rabbit corneal stroma. PLoS One. 2013;8(1):e52860. PubMed PMC
Hellander-Edman A, Makdoumi K, Mortensen J, Ekesten B. Corneal cross-linking in 9 horses with ulcerative keratitis. BMC Vet Res. 2013 Jun 26;9:128. PubMed PMC
Hollingsworth SR. Corneal surgical techniques. Clin Tech Small Anim Pract. 2003 Aug;18(3):161-7. PubMed
Ion L, Ionascu I, Birtoiu A. Melting keratitis in dogs and cats. Agric Agric Sci Procedia. 2015;6:342-9.
Kamaev P, Friedman MD, Sherr E, Muller D. Photochemical kinetics of corneal cross-linking with riboflavin. Invest Ophthalmol Vis Sci. 2012 Apr 30;53(4):2360-7. PubMed
Kim J, Ji DB, Takiyama N, Bae J, Kim MS. Corneal collagen cross-linking following superficial keratectomy as treatment for corneal endothelial cell dystrophy in dogs: Preliminary clinical study. Vet Ophthalmol. 2019 Jul;22(4):440-7. PubMed
Kumar V, Lockerbie O, Keil SD, Ruane PH, Platz MS, Martin CB, Ravanat JL, Cadet J, Goodrich RP. Riboflavin and UV-light based pathogen reduction: Extent and consequence of DNA damage at the molecular level. Photochem Photobiol. 2004 Jul-Aug;80:15-21. PubMed
Ledbetter EC, Dubovi EJ, Kim SG, Maggs DJ, Bicalho RC. Experimental primary ocular canine herpesvirus-1 infection in adult dogs. Am J Vet Res. 2009 Apr;70(4):513-21. Erratum in: Am J Vet Res. 2009 Jun;70(6): 740. PubMed
Lombardo M, Lombardo G. Noninvasive real-time assessment of riboflavin consumption in standard and accelerated corneal crosslinking. J Cataract Refract Surg. 2019 Jan;45(1):80-6. PubMed
Lombardo M, Pucci G, Barberi R, Lombardo G. Interaction of ultraviolet light with the cornea: Clinical implications for corneal crosslinking. J Cataract Refract Surg. 2015 Feb;41(2):446-59. PubMed
Lombardo G, Micali NL, Villari V, Serrao S, Lombardo M. All-optical method to assess stromal concentration of riboflavin in conventional and accelerated UV-A irradiation of the human cornea. Invest Ophthalmol Vis Sci. 2016 Feb;57(2):476-83. PubMed
Marchegiani A, Magagnini M, Cerquetella M, Troiano P, Franchini I, Franchini A, Scapagnini G, Spaterna A. Preoperative topical liposomal ozone dispersion to reduce bacterial colonization in conjunctival sac and periocular skin: Preliminary study in dogs. Exp Eye Res. 2019 Dec;189:107848. PubMed
Martins SA, Combs JC, Noguera G, Camacho W, Wittmann P, Walther R, Cano M, Dick J, Behrens A. Antimicrobial efficacy of riboflavin/UVA combination (365 nm) in vitro for bacterial and fungal isolates: A potential new treatment for infectious keratitis. Invest Ophthalmol Vis Sci. 2008 Aug;49(8):3402-8. PubMed
Murphy JM, Lavach JD, Severin GA. Survey of conjunctival flora in dogs with clinical signs of external eye disease. J Am Vet Med Assoc. 1978 Jan 1;172(1):66-8. PubMed
Ollivier FJ. Bacterial corneal diseases in dogs and cats. Clin Tech Small Anim Pract. 2003 Aug;18(3):193-8. PubMed
Ollivier FJ, Brooks DE, Kallberg ME, Komaromy AM, Lassaline ME, Andrew SE, Gelatt KN, Stevens GR, Blalock TD, van Setten GB, Schultz GS. Evaluation of various compounds to inhibit activity of matrix metalloproteinases in the tear film of horses with ulcerative keratitis. Am J Vet Res. 2003 Sep;64(9):1081-7. PubMed
Ollivier FJ, Gilger BC, Barrie KP, Kallberg ME, Plummer CE, O’Reilly S, Gelatt KN, Brooks DE. Proteinases of the cornea and preocular tear film. Vet Ophthalmol. 2007 Jul-Aug;10(4):199-206. PubMed
Perazzi A, Peruffo A, Gomiero C, Contin R, Corain L, Grisan E, Lombardo M, Lombardo G, Salvalaio G, Patruno M, Iacopetti I, Martinello T. Assessment of uv-a/riboflavin corneal cross-linking efficacy for the treatment of experimentally induced. International CXL experts meeting, Switzerland; 2018. p. 2014-5.
Perazzi A, Gomiero C, Corain L, Iacopetti I, Grisan E, Lombardo M, Lombardo G, Salvalaio G, Contin R, Patruno M, Martinello T, Peruffo A. An assay system to evaluate riboflavin/UV-A corneal phototherapy efficacy in a porcine corneal organ culture model. Animals (Basel). 2020 Apr 23;10(4):730. PubMed PMC
Pot SA, Gallhofer NS, Matheis FL, Voelter-Ratson K, Hafezi F, Spiess BM. Corneal collagen cross-linking as treatment for infectious and noninfectious corneal melting in cats and dogs: Results of a prospective, nonrandomized, controlled trial. Vet Ophthalmol. 2014 Jul;17(4):250-60. PubMed
Pot SA, Gallhofer NS, Walser-Reinhardt L, Hafezi F, Spiess BM. Treatment of bullous keratopathy with corneal collagen cross-linking in two dogs. Vet Ophthalmol. 2015 Mar;18(2):168-73. PubMed
Sondergaard AP, Ivarsen A, Hjortdal J. Reduction of stromal swelling pressure after UVA-riboflavin cross-linking. Invest Ophthalmol Vis Sci. 2013 Mar 5;54(3):1625-34. PubMed
Spadea L, Tonti E, Spaterna A, Marchegiani A. Use of ozone-based eye drops: A series of cases in veterinary and human spontaneous ocular pathologies. Case Rep Ophthalmol. 2018;9(2):287-8. PubMed PMC
Spiess BM, Pot SA, Florin M, Hafezi F. Corneal collagen cross-linking (CXL) for the treatment of melting keratitis in cats and dogs: A pilot study. Vet Ophthalmol. 2014 Jan;17(1):1-11. PubMed
Spoerl E, Wollensak G, Seiler T. Increased resistance of crosslinked cornea against enzymatic digestion. Curr Eye Res. 2004 Jul;29(1):35-40. PubMed
Spoerl E, Mrochen M, Sliney D, Trokel S, Seiler T. Safety of UVA-riboflavin cross-linking of the cornea. Cornea. 2007 May;26(4):385-9. PubMed
Tabibian D, Mazzotta C, Hafezi F. PACK-CXL: Corneal cross-linking in infectious keratitis. Eye Vis (Lond). 2016 Apr 19;3:11. PubMed PMC
Varges R, Penna B, Martins G, Martins R, Lilenbaum W. Antimicrobial susceptibility of Staphylococci isolated from naturally occurring canine external ocular diseases. Vet Ophthalmol. 2009 Jul-Aug;12(4):216-20. PubMed
Wang L, Pan Q, Zhang L, Xue Q, Cui J, Qi C. Investigation of bacterial microorganisms in the conjunctival sac of clinically normal dogs and dogs with ulcerative keratitis in Beijing, China. Vet Ophthalmol. 2008 May-Jun;11(3):145-9. PubMed
Wollensak G, Spoerl E, Reber F, Seiler T. Keratocyte cytotoxicity of riboflavin/UVA-treatment in vitro. Eye (Lond). 2004 Jul;18(7):718-22. PubMed